Table of Content

1. Introduction



2. Research & Methodology



3. Executive Summary



4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges


5. Global Lung Cancer Diagnostics Market



6. Market Share
6.1 By Diagnosis Test Type
6.2 By Cancer Type
6.3 By EndUsers
6.4 By Country


7. Diagnosis Test Type
7.1 Imaging Test
7.2 Biopsy
7.3 Sputum Cytology
7.4 Molecular Test
7.5 Others


8. Cancer Type
8.1 Non- Small Cell Lung Cancer
8.2 Small Cell Lung Cancer


9. End-User
9.1 Hospital Associated Labs
9.2 Independent Diagnostic Laboratories
9.3 Diagnostic Imaging Centers
9.4 Cancer Research Institutes
9.5 Others


10. Country
10.1 North America

10.1.1 United States
10.1.2 Canada

10.2 Europe

10.2.1 France
10.2.2 Germany
10.2.3 Italy
10.2.4 Spain
10.2.5 United Kingdom
10.2.6 Belgium
10.2.7 Netherlands
10.2.8 Turkey

10.3 Asia Pacific

10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 South Korea
10.3.5 Thailand
10.3.6 Malaysia
10.3.7 Indonesia
10.3.8 Australia
10.3.9 New Zealand

10.4 Latin America

10.4.1 Brazil
10.4.2 Mexico
10.4.3 Argentina

10.5 Middle East & Africa

10.5.1 Saudi Arabia
10.5.2 UAE
10.5.3 South Africa


11. Porter’s Five Analysis
11.1 Bargaining Power of Buyers
11.2 Bargaining Power of Suppliers
11.3 Degree of Rivalry
11.4 Threat of New Entrants
11.5 Threat of Substitutes


12. SWOT Analysis
12.1 Strength
12.2 Weakness
12.3 Opportunity
12.4 Threat


13. Company Analysis
13.1 llumina

13.1.1 Overviews
13.1.2 Recent Development
13.1.3 Revenues

13.2 Abbott Laboratories

13.2.1 Overviews
13.2.2 Recent Development
13.2.3 Revenues

13.3 Thermo Fisher Scientific, Inc

13.3.1 Overviews
13.3.2 Recent Development
13.3.3 Revenues

13.4 QIAGEN N.V.

13.4.1 Overviews
13.4.2 Recent Development
13.4.3 Revenues

13.5 Roche Holding AG.

13.5.1 Overviews
13.5.2 Recent Development
13.5.3 Revenues

13.6 Sanofi S.A.

13.6.1 Overview
13.6.2 Recent Development
13.6.3 Financial Insights

13.7 Agilent Technologies

13.7.1 Overview
13.7.2 Recent Development
13.7.3 Financial Insights

13.8 bioM?rieux

13.8.1 Overview
13.8.2 Recent Development
13.8.3 Financial Insights



List of Figures

0

List of Tables

0